ASX - Day Trading
|
|
Re:
Afternoon trading September 1
|
|
nifty49
|
410 |
113K |
1 |
01/09/20 |
01/09/20 |
ASX - Day Trading
|
410
|
113K
|
1
|
|
ASX - By Stock
|
3DP |
Re:
Ann: Enterprise Sales & ACV Update
|
|
nifty49
|
419 |
157K |
3 |
01/09/20 |
01/09/20 |
ASX - By Stock
|
419
|
157K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Tracking Valuations
|
|
nifty49
|
322 |
170K |
4 |
31/08/20 |
31/08/20 |
ASX - By Stock
|
322
|
170K
|
4
|
|
ASX - By Stock
|
BUD |
Re:
Ann: LIFX Announces World-First Disinfecting Anti-Bac Smart Light
|
|
nifty49
|
285 |
100K |
11 |
28/08/20 |
28/08/20 |
ASX - By Stock
|
285
|
100K
|
11
|
|
ASX - By Stock
|
CXZ |
Re:
Ann: Change of Director's Interest Notice
|
|
nifty49
|
231 |
68K |
1 |
27/08/20 |
27/08/20 |
ASX - By Stock
|
231
|
68K
|
1
|
|
ASX - By Stock
|
CXZ |
Re:
Earnings increasing & multiples expanding (Re-rate commencing)
|
|
nifty49
|
1.3K |
379K |
11 |
25/08/20 |
25/08/20 |
ASX - By Stock
|
1.3K
|
379K
|
11
|
|
ASX - By Stock
|
MVP |
Re:
Ann: Medical Developments to take control of EU markets
|
|
nifty49
|
13 |
4.8K |
4 |
20/08/20 |
20/08/20 |
ASX - By Stock
|
13
|
4.8K
|
4
|
|
ASX - By Stock
|
NST |
Re:
Ann: 2020 Annual Report to Shareholders
|
|
nifty49
|
7 |
3.1K |
0 |
19/08/20 |
19/08/20 |
ASX - By Stock
|
7
|
3.1K
|
0
|
|
ASX - By Stock
|
ADO |
Re:
Ann: AnteoTech Secures $3.76M Option Underwriting Agreement
|
|
nifty49
|
179 |
45K |
14 |
18/08/20 |
18/08/20 |
ASX - By Stock
|
179
|
45K
|
14
|
|
ASX - By Stock
|
MSB |
Re:
Ryoncil: ODAC/FDA Meeting Discussion
|
|
nifty49
|
2.0K |
693K |
9 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
2.0K
|
693K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Pick the Closing Price after FDA approval on that day
|
|
nifty49
|
449 |
190K |
2 |
10/08/20 |
10/08/20 |
ASX - By Stock
|
449
|
190K
|
2
|
|
ASX - By Stock
|
BGL |
Re:
Ann: Bellevue Share Purchase Plan closes this Friday
|
|
nifty49
|
54 |
26K |
1 |
06/08/20 |
06/08/20 |
ASX - By Stock
|
54
|
26K
|
1
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
nifty49
|
23K |
13M |
6 |
05/08/20 |
05/08/20 |
ASX - By Stock
|
23K
|
13M
|
6
|
|
ASX - By Stock
|
GMV |
Re:
Ann: Trading Halt
|
|
nifty49
|
98 |
30K |
13 |
05/08/20 |
05/08/20 |
ASX - By Stock
|
98
|
30K
|
13
|
|
ASX - Day Trading
|
|
Re:
Day trading pre-market open August 4
|
|
nifty49
|
123 |
42K |
3 |
04/08/20 |
04/08/20 |
ASX - Day Trading
|
123
|
42K
|
3
|
|
ASX - By Stock
|
MGV |
Re:
Ann: Bonanza gold grades continue at Starlight 3m @ 884.7 g/t Au
|
|
nifty49
|
481 |
171K |
8 |
28/07/20 |
28/07/20 |
ASX - By Stock
|
481
|
171K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Expands Executive Leadership Team
|
|
nifty49
|
170 |
80K |
17 |
24/07/20 |
24/07/20 |
ASX - By Stock
|
170
|
80K
|
17
|
|
ASX - By Stock
|
PTX |
Re:
Ann: 2 PTX Assets Chosen in Doherty Institute COVID-19 Program
|
|
nifty49
|
107 |
35K |
8 |
21/07/20 |
21/07/20 |
ASX - By Stock
|
107
|
35K
|
8
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
nifty49
|
23K |
13M |
3 |
06/07/20 |
06/07/20 |
ASX - By Stock
|
23K
|
13M
|
3
|
|
ASX - By Stock
|
MVP |
Re:
Yet another favorable report
|
|
nifty49
|
46 |
23K |
9 |
03/07/20 |
03/07/20 |
ASX - By Stock
|
46
|
23K
|
9
|
|
ASX - By Stock
|
GSS |
Re:
Bell Potter's top picks for FY21
|
|
nifty49
|
44 |
16K |
2 |
03/07/20 |
03/07/20 |
ASX - By Stock
|
44
|
16K
|
2
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
nifty49
|
23K |
13M |
0 |
30/06/20 |
30/06/20 |
ASX - By Stock
|
23K
|
13M
|
0
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
nifty49
|
23K |
13M |
0 |
23/06/20 |
23/06/20 |
ASX - By Stock
|
23K
|
13M
|
0
|
|
ASX - By Stock
|
OVN |
Re:
Ann: Share Purchase Plan closes oversubscribed
|
|
nifty49
|
44 |
9.2K |
0 |
22/06/20 |
22/06/20 |
ASX - By Stock
|
44
|
9.2K
|
0
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
nifty49
|
23K |
13M |
11 |
21/06/20 |
21/06/20 |
ASX - By Stock
|
23K
|
13M
|
11
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
nifty49
|
23K |
13M |
6 |
20/06/20 |
20/06/20 |
ASX - By Stock
|
23K
|
13M
|
6
|
|
ASX - By Stock
|
GSS |
Re:
Ann: Investor Presentation
|
|
nifty49
|
96 |
35K |
1 |
15/06/20 |
15/06/20 |
ASX - By Stock
|
96
|
35K
|
1
|
|
ASX - By Stock
|
JRV |
Re:
Pumped for the BFS
|
|
nifty49
|
81 |
16K |
0 |
11/06/20 |
11/06/20 |
ASX - By Stock
|
81
|
16K
|
0
|
|
ASX - By Stock
|
IDX |
Re:
Ann: Acquisition of Ascot Radiology (NZ)
|
|
nifty49
|
13 |
5.5K |
3 |
10/06/20 |
10/06/20 |
ASX - By Stock
|
13
|
5.5K
|
3
|
|
ASX - By Stock
|
OVN |
Re:
Ann: Oventus and Aeroflow further expand Lab in Lab contract
|
|
nifty49
|
15 |
6.3K |
2 |
09/06/20 |
09/06/20 |
ASX - By Stock
|
15
|
6.3K
|
2
|
|
ASX - By Stock
|
MGV |
Re:
6 metres @ 498.2 g/t Au
|
|
nifty49
|
63 |
22K |
3 |
09/06/20 |
09/06/20 |
ASX - By Stock
|
63
|
22K
|
3
|
|
ASX - By Stock
|
QFE |
Re:
QFE - Chart
|
|
nifty49
|
851 |
438K |
1 |
03/06/20 |
03/06/20 |
ASX - By Stock
|
851
|
438K
|
1
|
|
ASX - By Stock
|
MGV |
Re:
Ann: 12m @112.9g/t gold intersected near surface at Starlight
|
|
nifty49
|
103 |
36K |
4 |
03/06/20 |
03/06/20 |
ASX - By Stock
|
103
|
36K
|
4
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
nifty49
|
23K |
13M |
10 |
31/05/20 |
31/05/20 |
ASX - By Stock
|
23K
|
13M
|
10
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
nifty49
|
23K |
13M |
12 |
29/05/20 |
29/05/20 |
ASX - By Stock
|
23K
|
13M
|
12
|
|
ASX - By Stock
|
PCK |
Re:
June 2021 & 2022 Share Price Predictions
|
|
nifty49
|
178 |
67K |
2 |
29/05/20 |
29/05/20 |
ASX - By Stock
|
178
|
67K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: 3 Articles on RYONCIL GvHD Trial Results Published in BBMT
|
|
nifty49
|
127 |
71K |
2 |
26/05/20 |
26/05/20 |
ASX - By Stock
|
127
|
71K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Capital raising
|
|
nifty49
|
197 |
72K |
0 |
18/05/20 |
18/05/20 |
ASX - By Stock
|
197
|
72K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Completes Financing For Covid-19 ARDS Manufacturing
|
|
nifty49
|
116 |
58K |
5 |
13/05/20 |
13/05/20 |
ASX - By Stock
|
116
|
58K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
2 Thumbs Up for Mesoblast
|
|
nifty49
|
72 |
45K |
5 |
08/05/20 |
08/05/20 |
ASX - By Stock
|
72
|
45K
|
5
|
|
ASX - By Stock
|
MVP |
Re:
Opportunities for MVP in the current climate
|
|
nifty49
|
6 |
3.7K |
0 |
15/04/20 |
15/04/20 |
ASX - By Stock
|
6
|
3.7K
|
0
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
nifty49
|
23K |
13M |
3 |
10/04/20 |
10/04/20 |
ASX - By Stock
|
23K
|
13M
|
3
|
|
ASX - Day Trading
|
|
Re:
Day trading pre-market open April 9
|
|
nifty49
|
81 |
23K |
4 |
09/04/20 |
09/04/20 |
ASX - Day Trading
|
81
|
23K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Clears IND for Remestemcel Use in COVID-19 ARDS Patients
|
|
nifty49
|
311 |
166K |
17 |
06/04/20 |
06/04/20 |
ASX - By Stock
|
311
|
166K
|
17
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
nifty49
|
23K |
13M |
6 |
02/04/20 |
02/04/20 |
ASX - By Stock
|
23K
|
13M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts BLA for RYONCIL and Agrees to Priority Review
|
|
nifty49
|
131 |
54K |
6 |
01/04/20 |
01/04/20 |
ASX - By Stock
|
131
|
54K
|
6
|
|
ASX - By Stock
|
TYR |
Re:
$4 Party
|
|
nifty49
|
36 |
25K |
2 |
04/02/20 |
04/02/20 |
ASX - By Stock
|
36
|
25K
|
2
|
|
ASX - By Stock
|
NST |
Re:
NST SPP Closed
|
|
nifty49
|
8 |
5.7K |
0 |
29/01/20 |
29/01/20 |
ASX - By Stock
|
8
|
5.7K
|
0
|
|
ASX - By Stock
|
MVP |
Re:
Ann: CEO Roadshow Presentation
|
|
nifty49
|
297 |
160K |
1 |
29/01/20 |
29/01/20 |
ASX - By Stock
|
297
|
160K
|
1
|
|
ASX - By Stock
|
NST |
Re:
NST SPP Closed
|
|
nifty49
|
8 |
5.7K |
3 |
25/01/20 |
25/01/20 |
ASX - By Stock
|
8
|
5.7K
|
3
|
|